MediBeacon is based in St. Louis. It has raised $23M in total funding. Latest round: Series A.
MediBeacon funding overview
MediBeacon is based in St. Louis. MediBeacon has raised $23M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in January 2015. The round record for MediBeacon runs through 2015; nothing later has been disclosed. Investors on record include Pansend Life Sciences, Jump Capital, St. Louis BioGenerator, Missouri Technology Corporation, Helix Fund, St. Louis Development Corporation. 6 distinct backers are named across the disclosed rounds.
MediBeacon at a glance
Total raised
$23M
Latest round
Series A
Latest round date
January 2015
Headquarters
St. Louis
Notable investors
Pansend Life Sciences, Jump Capital, St. Louis BioGenerator, Missouri Technology Corporation, Helix Fund, St. Louis Development Corporation
Frequently asked about MediBeacon funding
How much has MediBeacon raised?
MediBeacon has raised $23M in total disclosed funding across the rounds on record.
Who has invested in MediBeacon?
Pansend Life Sciences, Jump Capital, St. Louis BioGenerator, Missouri Technology Corporation, Helix Fund, St. Louis Development Corporation are named among the investors backing MediBeacon.
What was the latest MediBeacon funding round?
The most recent disclosed round is a Series A, announced in January 2015.
Where is MediBeacon based?
MediBeacon is based in St. Louis.
When did MediBeacon last raise?
The last disclosed MediBeacon round closed in January 2015 at Series A.
We update the MediBeacon record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in St. Louis and their backers are listed below.
